Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Metastatic Prostate Cancer
Related studies linked through entity extraction aliases.
Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects
- Status
- COMPLETED
- Phase
- PHASE2
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Phase I Trial of PACE for Metastatic Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
- Status
- TERMINATED
- Phase
- N/A
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to Castration
- Status
- UNKNOWN
- Phase
- NA
One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC)
- Status
- TERMINATED
- Phase
- PHASE1
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)
- Status
- COMPLETED
- Phase
- N/A
Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Prospective Evaluation of Stereotactic Body Radiotherapy for Metastatic Prostate Cancer
- Status
- WITHDRAWN
- Phase
- NA